27/11/2024
PlusVitech Wins at World Business Angels Investment Forum Bahrein 2024!
We are proud to announce that PlusVitech emerged as one of the winners in the Global Fundraising Stage at the World Business Angels Investment Forum (WBAF) held on November 19-20 at the Four Seasons Hotel Manama. Sponsored by Crown Prince Salman bin Hamad Al Khalifa, the event brought together over 500 attendees and innovative startups from around the world.
Our CEO, Dr. Vicente Salinas , and General Manager, Fran Guillén , presented our revolutionary cancer drug to a distinguished jury of 20 international investors from Bahrain, Dubai, India, Italy, Korea, and more. Winning this competition advances us to the due diligence phase with the WBAF Fund, alongside two other exceptional companies.
Fran Guillén remarked, “Receiving this award is a great honor and a testament to years of dedication. This new investment round will enable us to bring our groundbreaking cancer treatment to market soon.”
Dr. Vicente Salinas added, “This recognition motivates us to continue our mission to provide effective and safe treatment options for patients with advanced cancer.”
In addition to this achievement, PlusVitech was awarded the European Commission’s Seal of Excellence in 2023 and recently partnered with Nanoform (NASDAQ: NAHOFH). These milestones support our goal to launch our innovative drug PVT-01 by 2026.
Thank you to all our supporters and partners for believing in our vision. Together, we are transforming cancer treatment and improving lives worldwide.
https://www.plusvitech.com/en/plusvitech-a-seville-based-cancer-drug-development-company-has-been-one-of-the-winners-of-the-world-business-angels-investment-forum-wbaf-2024-held-in-manama-bahrain/